Gomollón F - Search Results

1

Risk of Cancer in Patients with Inflammatory Bowel Diseases and Keys for Patient Management.

Laredo V, García-Mateo S, Martínez-Domínguez SJ, López de la Cruz J, Gargallo-Puyuelo CJ, Gomollón F. Laredo V, et al. Among authors: gomollon f. Cancers (Basel). 2023 Jan 31;15(3):871. doi: 10.3390/cancers15030871. Cancers (Basel). 2023. PMID: 36765829 Free PMC article. Review.

2

[Inflammatory bowel disease].

Gomollón F. Gomollón F. Gastroenterol Hepatol. 2008 Oct;31 Suppl 4:42-6. doi: 10.1016/s0210-5705(08)76628-7. Gastroenterol Hepatol. 2008. PMID: 19434865 Spanish.

3

Intravenous iron in inflammatory bowel diseases.

Gomollón F, Gisbert JP. Gomollón F, et al. Curr Opin Gastroenterol. 2013 Mar;29(2):201-7. doi: 10.1097/MOG.0b013e32835bdc2e. Curr Opin Gastroenterol. 2013. PMID: 23274316 Review.

4

[Treatment of inflammatory bowel diseases].

Gomollón F. Gomollón F. Gastroenterol Hepatol. 2015 Sep;38 Suppl 1:13-9. doi: 10.1016/S0210-5705(15)30015-7. Gastroenterol Hepatol. 2015. PMID: 26520192 Review. Spanish.

5

Iron Treatment May Be Difficult in Inflammatory Diseases: Inflammatory Bowel Disease as a Paradigm.

Gargallo-Puyuelo CJ, Alfambra E, García-Erce JA, Gomollon F. Gargallo-Puyuelo CJ, et al. Among authors: gomollon f. Nutrients. 2018 Dec 11;10(12):1959. doi: 10.3390/nu10121959. Nutrients. 2018. PMID: 30544934 Free PMC article. Review.

6

Bioequivalence studies with anti-TNF biosimilars.

Gimeno-Gracia M, Gargallo-Puyuelo CJ, Gomollón F. Gimeno-Gracia M, et al. Among authors: gomollon f. Expert Opin Biol Ther. 2019 Oct;19(10):1031-1043. doi: 10.1080/14712598.2019.1561851. Epub 2018 Dec 31. Expert Opin Biol Ther. 2019. PMID: 30574813 Review.

7

Young age and tobacco use are predictors of lower medication adherence in inflammatory bowel disease.

Bruna-Barranco I, Lué A, Gargallo-Puyuelo CJ, Arroyo MT, Alfambra E, Montero J, Gomollón F. Bruna-Barranco I, et al. Among authors: gomollon f. Eur J Gastroenterol Hepatol. 2019 Aug;31(8):948-953. doi: 10.1097/MEG.0000000000001436. Eur J Gastroenterol Hepatol. 2019. PMID: 31107739

8

Inflammatory bowel disease and the risk of cardiovascular diseases.

Nuñez P, García Mateo S, Quera R, Gomollón F. Nuñez P, et al. Among authors: gomollon f. Gastroenterol Hepatol. 2021 Mar;44(3):236-242. doi: 10.1016/j.gastrohep.2020.09.002. Epub 2020 Oct 20. Gastroenterol Hepatol. 2021. PMID: 33223261 Review. English, Spanish.

9

Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?

Gargallo-Puyuelo CJ, Laredo V, Gomollón F. Gargallo-Puyuelo CJ, et al. Among authors: gomollon f. Front Med (Lausanne). 2021 Jul 16;8:681907. doi: 10.3389/fmed.2021.681907. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34336887 Free PMC article. Review.

10

Small and Large Intestine (II): Inflammatory Bowel Disease, Short Bowel Syndrome, and Malignant Tumors of the Digestive Tract.

Ber Y, García-Lopez S, Gargallo-Puyuelo CJ, Gomollón F. Ber Y, et al. Among authors: gomollon f. Nutrients. 2021 Jul 6;13(7):2325. doi: 10.3390/nu13072325. Nutrients. 2021. PMID: 34371835 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

269 results

Search Page